MTHFD2 and acute myeloid leukemia: Moreover, we noticed that approximately 20% of the responding cancer cells consistently survived despite increasing concentrations of MTHFD2 inhibitors (Fig. 3a), which could be related to earlier observations that MTHFD2 knockdown induces AML differentiation19.